A bill for an act relating to the medical cannabidiol program including medical cannabidiol dispensaries.
Impact
The bill introduces significant changes to the regulatory framework surrounding medical cannabidiol dispensaries, allowing current licensees to apply for additional permits under specific conditions. The Department of Health and Human Services is tasked with accepting applications from current licensees and is directed to consider factors such as security and physical layout when evaluating applications. However, under the new provisions, no new dispensary licenses will be granted in counties that already have a licensed dispensary established before January 1, 2023, which may limit the growth potential in certain regions.
Summary
Senate Study Bill 1113 is an act focusing on the medical cannabidiol program in Iowa, specifically concerning medical cannabidiol dispensaries. The bill proposes amendments to increase the number of licensed medical cannabidiol dispensaries in Iowa from five to ten and updates the definition of 'medical cannabidiol' to include various forms of oral, topical, and inhalable cannabis. The legislative intent behind this bill appears to enhance patient access to medical cannabis while expanding the capacity for dispensaries to operate within the state.
Contention
One point of contention among stakeholders may arise from the limitation imposed on new dispensary licenses, as it could prevent expansion in areas potentially underserved by current operations. Critics might argue that this restriction undermines efforts to improve access to medical cannabis, particularly in rural or less populated areas. The decision to no longer require geographical assessment for locating dispensaries could also lead to debates on equitable access to medical cannabis for patients across various county lines.
A bill for an act relating to the issuance of medical cannabidiol registration cards and licensure of medical cannabidiol dispensaries. (Formerly HSB 224.) Effective date: 07/01/2026
A bill for an act relating to medical cannabidiol by providing deductions from the individual and corporate income taxes for expenses incurred by medical cannabidiol manufacturers and dispensaries, and including retroactive applicability provisions.
A bill for an act relating to the issuance of medical cannabidiol registration cards and licensure of medical cannabidiol dispensaries. (Formerly HSB 224.) Effective date: 07/01/2026
A bill for an act relating to medical cannabidiol by providing deductions from the individual and corporate income taxes for expenses incurred by medical cannabidiol manufacturers and dispensaries, and including retroactive applicability provisions.